Geovax Labs, Inc.
SEC CIK 832489 · GOVX.OB · last insider filing 2026-06-22
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Mcnally Robert T | Director · President/CEO | filed 2006–2026 |
| Chase Randal D | Director | filed 2015–2026 |
| Dodd David A | Director · President, CEO | filed 2010–2026 |
| Spencer John N JR | Director | filed 2006–2026 |
| Kollintzas Dean G | Director | filed 2006–2026 |
| Lemerond Nicole | Director | filed 2022–2026 |
| Morgan Jayne | Director | filed 2022–2026 |
| Robinson Harriet L | Director · SVP, Research & Development | filed 2006–2018 |
| Antebi Steven S. | Director | filed 2010–2012 |
| Hildebrand Donald G | Director · President & CEO | filed 2006–2010 |
| Tsolinas Peter M | Director | filed 2008–2010 |
| Kandalepas Andrew J | Director · Senior Vice President | filed 2007–2008 |
| Teal Gary | Director | filed 2006–2006 |
| Murphree Edith | Director | filed 2006–2006 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Newman Mark J | VP, Research & Development | filed 2010–2026 |
| Reynolds Mark | Chief Financial Officer | filed 2006–2026 |
| Sharkey John W. | VP, Business Development | filed 2022–2026 |
| Mckee Kelly T. Jr. | Chief Medical Officer | filed 2022–2026 |
| Guirakhoo Farshad | Sr VP, Research & Development | filed 2015–2018 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.